The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
5-Hydroxytryptamine receptors in the human cardiovascular system
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Le Mouroux, A., Le Métayer, P., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 7,975
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Atrial Fibrillation Begets Atrial Fibrillation: A Study in Awake Chronically Instrumented Goats
Wijffels, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,494
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hamberg, M., Svensson, J., & Samuelsson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,003
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Migraine — Current Understanding and Treatment
Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010917 · Cited by 1,918
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632 · cited 1×
“Evidence for endothelium-dependent dilation of the perfused renal arterial bed of the rat by 5-HT, 5CT and 8-OH-DPAT in the presence of ritanserin (to block 5HT2A receptors) and tropisetron (to block 5-HT3 receptors) has been provided by Verbeuren et al. (1991). They showed that the agonist-mediated dilation was suppr…”
BackgroundCharacterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547
New ideas about atrial fibrillation 50 years on
Nattel, S. (2002) · Nature · doi:10.1038/415219a · Cited by 1,481
Pulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,463
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Progressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic mice
Engelhardt, S., Hein, L., Wiesmann, F., & Lohse, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7059 · Cited by 785
Kulke, M. H., & Mayer, R. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401107 · Cited by 741
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Weiss, E. J., Bray, P. F., Tayback, M., Schulman, S. P., Kickler, T. S., Becker, L. C., Weiss, J. L., Gerstenblith, G., & Goldschmidt-Clermont, P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341703 · Cited by 689
Eddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 579
The 5-HT3B subunit is a major determinant of serotonin-receptor function
Davies, P. A., Pistis, M., Hanna, M. C., Peters, J. A., Lambert, J. J., Hales, T. G., & Kirkness, E. F. (1999) · Nature · doi:10.1038/16941 · Cited by 561
Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.
Feldman, A. M., Cates, A. E., Veazey, W. B., Hershberger, R. E., Bristow, M. R., Baughman, K. L., Baumgartner, W. A., & Van Dop, C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113569 · Cited by 543
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
Bard, J. A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T. A., & Weinshank, R. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49479-9 · Cited by 533
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
Van Nueten, J. M., Janssen, P. A., Van Beek, J., Xhonneux, R., Verbeuren, T. J., & Vanhoutte, P. M. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32655-8 · Cited by 520
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Côté, F., Thévenot, E., Fligny, C., Fromes, Y., Darmon, M., Ripoche, M.-A., Bayard, E., Hanoun, N., Saurini, F., Lechat, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233056100 · Cited by 483
Walther, D. J., Peter, J.-U., Winter, S., Höltje, M., Paulmann, N., Grohmann, M., Vowinckel, J., Alamo-Bethencourt, V., Wilhelm, C. S., Ahnert-Hilger, G., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)01014-6 · Cited by 475
Multiplicity of mechanisms of serotonin receptor signal transduction
Raymond, J. R., Mukhin, Y. V., Gelasco, A., Turner, J., Collinsworth, G., Gettys, T. W., Grewal, J. S., & Garnovskaya, M. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00169-3 · Cited by 466
Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine
Fitzgerald, L. W., Burn, T. C., Brown, B. S., Patterson, J. P., Corjay, M. H., Valentine, P. A., Sun, J.-H., Link, J. R., Abbaszade, I., Hollis, J. M., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26444-0 · Cited by 440
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J.-M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C. G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors
Fozard, J. R. (1984) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00518776 · Cited by 429
Golino, P., Piscione, F., Willerson, J. T., Cappelli-Bigazzi, M., Focaccio, A., Villari, B., Indolfi, C., Russolillo, E., Condorelli, M., & Chiariello, M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241001 · Cited by 426
Block, J. A., & Sequeira, W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05118-7 · Cited by 422
Wigley, F. M., & Flavahan, N. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507638 · Cited by 420
Haïssaguerre, M., Sanders, P., Hocini, M., Hsu, L.-F., Shah, D. C., Scavée, C., Takahashi, Y., Rotter, M., Pasquié, J.-L., Garrigue, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130645.95357.97 · Cited by 407
Robiolio, P. A., Rigolin, V. H., Wilson, J. S., Harrison, J. K., Sanders, L. L., Bashore, T. M., & Feldman, J. M. (1995) · Circulation · doi:10.1161/01.cir.92.4.790 · Cited by 406
Cell adhesion molecules in coronary artery disease
Jang, Y., Lincoff, A. M., Plow, E. F., & Topol, E. J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90162-7 · Cited by 395
Wigley, F. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013013 · Cited by 394
Hyperdynamic Circulation of Liver Disease 40 Years Later: Pathophysiology and Clinical Consequences
Groszmann, R. J. (1994) · Hepatology · doi:10.1002/hep.1840200538 · Cited by 387
Serotonin 2B receptor is required for heart development
Nebigil, C. G., Choi, D.-S., Dierich, A., Hickel, P., Le Meur, M., Messaddeq, N., Launay, J.-M., & Maroteaux, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9508 · Cited by 381
McFadden, E. P., Clarke, J. G., Davies, G. J., Kaski, J. C., Haider, A. W., & Maseri, A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241002 · Cited by 360
Dodick, D., Lipton, R. B., Martin, V., Papademetriou, V., Rosamond, W., MaassenVanDenBrink, A., Loutfi, H., Welch, K. M., Goadsby, P. J., Hahn, S., et al. (2004) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2004.04078.x · Cited by 351
Expression of serotonin receptor mRNAs in blood vessels
Ullmer, C., Schmuck, K., Kalkman, H. O., & Lübbert, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00828-w · Cited by 339
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs
MaassenVanDenBrink, A., Reekers, M., Bax, W. A., Ferrari, M. D., & Saxena, P. R. (1998) · Circulation · doi:10.1161/01.cir.98.1.25 · Cited by 323
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
Mace, S., & Taylor, D. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.917 · Cited by 315
SAITO, T., WAKI, K., & BECKER, A. E. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00068.x · Cited by 310
Bonhaus, D. W., Bach, C., DeSouza, A., Salazar, F. H. R., Matsuoka, B. D., Zuppan, P., Chan, H. W., & Eglen, R. M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14977.x · Cited by 305
Setola, V., Hufeisen, S. J., Grande-Allen, K. J., Vesely, I., Glennon, R. A., Blough, B., Rothman, R. B., & Roth, B. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1223 · Cited by 304
Factors Associated with Progression of Carcinoid Heart Disease
Møller, J. E., Connolly, H. M., Rubin, J., Seward, J. B., Modesto, K., & Pellikka, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021451 · Cited by 298
Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice
Hall, G. C., Brown, M. M., Mo, J., & MacRae, K. D. (2004) · Neurology · doi:10.1212/01.wnl.0000110312.36809.7f · Cited by 296
Serotonin Is Associated with Coronary Artery Disease and Cardiac Events
Vikenes, K., Farstad, M., & Nordrehaug, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.5.483 · Cited by 290
Dubin, A. E., Huvar, R., D'Andrea, M. R., Pyati, J., Zhu, J. Y., Joy, K. C., Wilson, S. J., Galindo, J. E., Glass, C. A., Luo, L., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30799 · Cited by 281
Hartig, P. R., Hoyer, D., Humphrey, P. P. A., & Martin, G. R. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)30002-3 · Cited by 280
A cytoplasmic region determines single-channel conductance in 5-HT3 receptors
Kelley, S. P., Dunlop, J. I., Kirkness, E. F., Lambert, J. J., & Peters, J. A. (2003) · Nature · doi:10.1038/nature01788 · Cited by 273
Nerves, Reflexes, and the Enteric Nervous System: Pathogenesis of the Irritable Bowel Syndrome
Gershon, M. D. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156403.37240.30 · Cited by 271 · cited 3×
“Recent evidence suggests that the molecularly elusive socalled 5-HT1P receptor found in the gut (Gershon, 2005) may represent an oligomeric form of the 5-HT1B receptor through interaction with either the D2 dopamine receptor (heterooligomers) or other 5-HT1B receptors (homooligomers; Liu & Gershon,…”
BackgroundA Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve Regurgitation
Jick, H., Vasilakis, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., & Derby, L. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391102 · Cited by 263
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine
Coleiro, B., Marshall, S. E., Denton, C. P., Howell, K., Blann, A., Welsh, K. I., & Black, C. M. (2001) · Rheumatology · doi:10.1093/rheumatology/40.9.1038 · Cited by 261
The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.
Gerald, C., Adham, N., Kao, H. T., Olsen, M. A., Laz, T. M., Schechter, L. E., Bard, J. A., Vaysse, P. J., Hartig, P. R., & Branchek, T. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07280.x · Cited by 260
The –1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity
Parsons, M. J., D'Souza, U. M., Arranz, M.-J., Kerwin, R. W., & Makoff, A. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.020 · Cited by 258
Long-Term Serotonin Administration Induces Heart Valve Disease in Rats
Gustafsson, B. I., Tømmerås, K., Nordrum, I., Loennechen, J. P., Brunsvik, A., Solligård, E., Fossmark, R., Bakke, I., Syversen, U., & Waldum, H. (2005) · Circulation · doi:10.1161/01.cir.0000159356.42064.48 · Cited by 257
Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response
Arranz, M. J., Munro, J., Sham, P., Kirov, G., Murray, R. M., Collier, D. A., & Kerwin, R. W. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00032-2 · Cited by 255
Spurlock, G., Heils, A., Holmans, P., Williams, J., D'Souza, U. M., Cardno, A., Murphy, K. C., Jones, L., Buckland, P. R., McGuffin, P., et al. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000342 · Cited by 254
Niesler, B., Frank, B., Kapeller, J., & Rappold, G. A. (2003) · Gene · doi:10.1016/s0378-1119(03)00503-1 · Cited by 252
Is Variant Angina the Coronary Manifestation of a Generalized Vasospastic Disorder?
Miller, D., Waters, D. D., Warnica, W., Szlachcic, J., Kreeft, J., & Théroux, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103263041306 · Cited by 249
Sauer, W. H., Berlin, J. A., & Kimmel, S. E. (2003) · Circulation · doi:10.1161/01.cir.0000079172.43229.cd · Cited by 247
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
Horvath, J., Fross, R. D., Kleiner‐Fisman, G., Lerch, R., Stalder, H., Liaudat, S., Raskoff, W. J., Flachsbart, K. D., Rakowski, H., Pache, J., et al. (2004) · Movement Disorders · doi:10.1002/mds.20201 · Cited by 243
Meller, S. T., & Gebhart, G. F. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90398-l · Cited by 234
Pathophysiology of Migraine — New Insights
Hargreaves, R., & Shepheard, S. (1999) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000147 · Cited by 234
Eddahibi, S., Chaouat, A., Morrell, N., Fadel, E., Fuhrman, C., Bugnet, A.-S., Dartevelle, P., Housset, B., Hamon, M., Weitzenblum, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091409.53101.e8 · Cited by 234
MacLean, M. R., Herve, P., Eddahibi, S., & Adnot, S. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703570 · Cited by 232
A subfamily of 5-HT1D receptor genes
Hartig, P. R., Branchek, T. A., & Weinshank, R. L. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90053-9 · Cited by 229
Paroxetine decreases platelet serotonin storage and platelet function in human beings
Hergovich, N. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110456 · Cited by 229
Kvachnina, E., Liu, G., Dityatev, A., Renner, U., Dumuis, A., Richter, D. W., Dityateva, G., Schachner, M., Voyno-Yasenetskaya, T. A., & Ponimaskin, E. G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1790-05.2005 · Cited by 227
HUMPHREY, P. P. A., FENIUK, W., PERREN, M. J., BERESFORD, I. J. M., SKINGLE, M., & WHALLEY, E. T. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16912.x · Cited by 226
Keegan, A., Morecroft, I., Smillie, D., Hicks, M. N., & MacLean, M. R. (2001) · Circulation Research · doi:10.1161/hh2401.100426 · Cited by 225
Heidmann, D. E. A., Metcalf, M. A., Kohen, R., & Hamblin, M. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041372.x · Cited by 221
Nilsson, T., Longmore, J., Shaw, D., Pantev, E., Bard, J. A., Branchek, T., & Edvinsson, L. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00114-4 · Cited by 215
A 5‐hydroxytryptamine receptor in human atrium
Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., & Brown, M. J. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14108.x · Cited by 204
Self-citationSerotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension
Marcos, E., Adnot, S., Pham, M. H., Nosjean, A., Raffestin, B., Hamon, M., & Eddahibi, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1212oc · Cited by 204
Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia
Williams, J., McGuffin, P., Nöthen, M., & Group, M. J. O. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62413-0 · Cited by 203
van den Berg, E. K., Schmitz, J. M., Benedict, C. R., Malloy, C. R., Willerson, J. T., & Dehmer, G. J. (1989) · Circulation · doi:10.1161/01.cir.79.1.116 · Cited by 202
Erdmann, J., Shimron-Abarbanell, D., Rietschel, M., Albus, M., Maier, W., Körner, J., Bondy, B., Chen, K., Shih, J. C., Knapp, M., et al. (1996) · Human Genetics · doi:10.1007/bf02281871 · Cited by 201
Claeysen, S., Sebben, M., Becamel, C., Bockaert, J., & Dumuis, A. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23188-6 · Cited by 197
Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension
Marcos, E., Fadel, E., Sanchez, O., Humbert, M., Dartevelle, P., Simonneau, G., Hamon, M., Adnot, S., & Eddahibi, S. (2004) · Circulation Research · doi:10.1161/01.res.0000126847.27660.69 · Cited by 195
Nebigil, C. G., Launay, J.-M., Hickel, P., Tournois, C., & Maroteaux, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050282397 · Cited by 183
Miyake, A., Mochizuki, S., Takemoto, Y., & Akuzawa, S. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10488-4 · Cited by 181
Mechanism of the Hypotensive Effect of Ketanserin
Fozard, J. R. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198209000-00020 · Cited by 180
Zucker, M. B., & Nachmias, V. T. (1985) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.5.1.2 · Cited by 179
Compan, V., Zhou, M., Grailhe, R., Gazzara, R. A., Martin, R., Gingrich, J., Dumuis, A., Brunner, D., Bockaert, J., & Hen, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2806-03.2004 · Cited by 178
Kilts, J. D., Gerhardt, M. A., Richardson, M. D., Sreeram, G. M., Mackensen, G. B., Grocott, H. P., White, W. D., Davis, R. D., Newman, M. F., Reves, J. G., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.8.705 · Cited by 177
Goldstein, D., Roon, K., Offen, W., Ramadan, N., Phebus, L., Johnson, K., Schaus, J., & Ferrari, M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06347-4 · Cited by 170
SB-216641 and BRL-15572 – compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors
Price, G. W., Burton, M. J., Collin, L. J., Duckworth, M., Gaster, L., Göthert, M., Jones, B. J., Roberts, C., Watson, J. M., & Middlemiss, D. N. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005056 · Cited by 168
Lefebvre, H., Contesse, V., Delarue, C., Feuilloley, M., Hery, F., Grise, P., Raynaud, G., Verhofstad, A. A. J., Wolf, L. M., & Vaudry, H. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90047-6 · Cited by 164
Boutjdir, M., Chen, L., Zhang, Z.-H., Tseng, C.-E., DiDonato, F., Rashbaum, W., Morris, A., El-Sherif, N., & Buyon, J. P. (1997) · Circulation Research · doi:10.1161/01.res.80.3.354 · Cited by 164
Excitation of afferent cardiac sympathetic nerve fibers during coronary occlusion
Uchida, Y., & Murao, S. (1974) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1974.226.5.1094 · Cited by 161
Triggle, D. J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474503 · Cited by 160
Hanna, G. L., Himle, J. A., Curtis, G. C., Koram, D. Q., Veenstra-VanderWeele, J., Leventhal, B. L., & Cook, E. H. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00097-3 · Cited by 160
Blondel, O., Gastineau, M., Dahmoune, Y., Langlois, M., & Fischmeister, R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062252.x · Cited by 159
Nebigil, C. G., Étienne-Selloum, N., Messaddeq, N., & Maroteaux, L. (2003) · The FASEB Journal · doi:10.1096/fj.02-1122fje · Cited by 158
Tremblay, P., Kaiser, R., Sezer, O., Rösler, N., Schelenz, C., Possinger, K., Roots, I., & Brockmöller, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.164 · Cited by 157
Robertson, T. P., Dipp, M., Ward, J. P. T., Aaronson, P. I., & Evans, A. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703537 · Cited by 155
Calcium Currents in Diseased Human Cardiac Cells
Ouadid, H., Albat, B., & Nargeot, J. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199502000-00014 · Cited by 152
Krobert, K. A., Bach, T., Syversveen, T., Kvingedal, A. M., & Levy, F. O. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000369 · Cited by 152
Self-citationStructure of the Human Serotonin 5‐HT4 Receptor Gene and Cloning of a Novel 5‐HT4 Splice Variant
Bender, E., Pindon, A., Oers, I. V., Zhang, Y., Gommeren, W., Verhasselt, P., Jurzak, M., Leysen, J. E., & Luyten, W. H. M. L. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740478.x · Cited by 145
PDZ-dependent Activation of Nitric-oxide Synthases by the Serotonin 2B Receptor
Manivet, P., Mouillet‐Richard, S., Callebert, J., Nebigil, C. G., Maroteaux, L., Hosoda, S., Kellermann, O., & Launay, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9324 · Cited by 141
Ouadid‐Ahidouch, H., Seguin, J. R., Dumuis, A., Bockaert, J., & Nargeot, J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08883-2 · Cited by 140
Duprez, D. A., Bauwens, F. R., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90240-d · Cited by 139
Hamel, É., Fan, E., Linville, D. G., Ting, V., Villemure, J., & Chia, L. S. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13136-2 · Cited by 139
Do human atrial 5-HT4 receptors mediate arrhythmias?
Kaumann, A. J. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90058-2 · Cited by 138
Self-citationLocal Effect of Serotonin Released during Coronary Angioplasty
Golino, P., Piscione, F., Benedict, C. R., Anderson, H. V., Cappelli-Bigazzi, M., Indolfi, C., Condorelli, M., Chiariello, M., & Willerson, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402243300802 · Cited by 138
Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine
Arranz, M. J., Collier, D. A., Munro, J., Sham, P. C., Kirov, G., Sodhi, M., Roberts, G. W., Price, J., & Kerwin, R. W. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13094-9 · Cited by 136
Jaffré, F., Callebert, J., Sarre, A., Étienne-Selloum, N., Nebigil, C. G., Launay, J., Maroteaux, L., & Monassier, L. (2004) · Circulation · doi:10.1161/01.cir.0000139856.20505.57 · Cited by 133
Ultrastructure of the 5‐Hydroxytryptamine3 Receptor
Boess, F., Beroukhim, R., & Martin, I. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031401.x · Cited by 133
Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene
Flomen, R. H., Knight, J., Sham, P. C., Kerwin, R. W., & MAKOFF, A. J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh536 · Cited by 131
Grailhe, R., Grabtree, G. W., & Hen, R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00933-5 · Cited by 130
Jasper, J. R., Kosaka, A. H., To, Z. P., Chang, D. J., & Eglen, R. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701336 · Cited by 130
Portal Hypertension: From Bedside to Bench
Groszmann, R. J., & Abraldeṣ, J. G. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155552.14396.3d · Cited by 129
Aminorex to Fen/Phen: An Epidemic Foretold
Fishman, A. P. (1999) · Circulation · doi:10.1161/01.cir.99.1.156 · Cited by 128
Nilsson, T., Longmore, J., Shaw, D. E., Olesen, I. J., & Edvinsson, L. I. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702773 · Cited by 125
Bach, T., Syversveen, T., Kvingedal, A. M., Krobert, K. A., Brattelid, T., Kaumann, A. J., & Levy, F. O. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000299 · Cited by 125
Self-citationCloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.
Belelli, D., Balcarek, J. M., Hope, A. G., Peters, J. A., Lambert, J. J., & Blackburn, T. P. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10574-9 · Cited by 124
The 5‐HT4 receptor agonist, tegaserod, is a potent 5‐HT2B receptor antagonist in vitro and in vivo
Beattie, D. T., Smith, J. A. M., Marquess, D. G., Vickery, R. G., Armstrong, S. R., Pulido‐Rios, T., McCullough, J. L., Sandlund, C., RICHARDSON, C. E., Mai, N., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705929 · Cited by 122
Possible Antimigraine Mechanisms of Action of the 5HT1F Receptor Agonist LY334370
Shepheard, S. L., Edvinsson, L. I., Cumberbatch, M. J., Williamson, D., Mason, G. S., Webb, J. K., Boyce, S., Hill, R. G., & Hargreaves, R. J. (1999) · Cephalalgia · doi:10.1046/j.1468-2982.1999.1910851.x · Cited by 122
Pindon, A., Hecke, G. V., Gompel, P. V., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.85 · Cited by 119
5-HT4Receptor Ligands: Applications and New Prospects
Langlois, M., & Fischmeister, R. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020099f · Cited by 119
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation
Laffi, G., Marra, F., Gresele, P., Romagnoli, P., Palermo, A., Bartolini, O., Simoni, A., Orlandi, L., Selli, M. L., Nenci, G. G., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90859-w · Cited by 118
The carcinoid endocardial plaque
Ferrans, V. J., & Roberts, W. C. (1976) · Human Pathology · doi:10.1016/s0046-8177(76)80054-8 · Cited by 114
Ozaki, N., Manji, H. K., Lubierman, V., Lu, S. J., Lappalainen, J., Rosenthal, N. E., & Goldman, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052186.x · Cited by 114
A 5-HT4-like receptor in human right atrium
Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., & Brown, M. J. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00167212 · Cited by 113
Self-citationGlusa, E., & Pertz, H. H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703341 · Cited by 112
Krobert, K. A., & Levy, F. O. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704588 · Cited by 111
Self-citationSharp, T., Backus, L. I., Hjorth, S., Bramwell, S. R., & Grahame‐Smith, D. G. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90027-4 · Cited by 108
Medhurst, A. D., Lezoualc’h, F., Fischmeister, R., Middlemiss, D. N., & Sanger, G. J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00095-x · Cited by 105
Molecular and functional characterization of a 5‐HT4 receptor cloned from human atrium
Blondel, O., Vandecasteele, G., Gastineau, M., Leclerc, S., Dahmoune, Y., Langlois, M., & Fischmeister, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00820-x · Cited by 101
Razzaque, Heald, Pickard, Maskell, Beer, Hill, & Longmore (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00851.x · Cited by 98
Bouchelet, I., Case, B. W., Olivier, A., & Hamel, É. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703081 · Cited by 97
Brattelid, T., Kvingedal, A. M., Krobert, K. A., Andressen, K. W., Bach, T., Hystad, M. E., Kaumann, A. J., & Levy, F. O. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0919-4 · Cited by 96
Self-citationEffect of 5-HT4 receptor stimulation on the pacemaker current If in human isolated atrial myocytes
Pino, R., Cerbai, E., Calamai, G., Alajmo, F., Borgioli, A., Braconi, L., Cassai, M., Montesi, G. F., & Mugelli, A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00198-9 · Cited by 94
5-Hydroxytryptamine 4(a) Receptor Is Coupled to the Gα Subunit of Heterotrimeric G13 Protein
Ponimaskin, E. G., Profirovic, J., Vaiškunaite, R., Richter, D. W., & Voyno-Yasenetskaya, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112216200 · Cited by 93
Cohen, Z., Bouchelet, I., Olivier, A., Villemure, J., Ball, R., Stanimirovic, D. B., & Hamel, É. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00010 · Cited by 93
Ergonovine-induced myocardial ischemia: no role for serotonergic receptors?
Freedman, B., Chierchia, S. L., Rodriguez-Plaza, L. G., et al. (1984) · Circulation · doi:10.1161/01.cir.70.2.178 · Cited by 92
Sun, H. S., Chang, Y.-T., Fann, C. S. J., Chang, C.-J., Chen, Y.-H., Hsu, Y. P., Yu, W.-Y., & Cheng, A. T.-A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01366-x · Cited by 90
Duan, J., Sanders, A. R., Molen, J. E. V., Martinolich, L., Mowry, B. J., Levinson, D. F., Crowe, R., Silverman, J. M., & Gejman, P. V. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001403 · Cited by 90
Sigmund, M., Jakob, H. G., Becker, H., Hanrath, P., Schumacher, C., Thomas Eschenhagen, A., Schmitz, W. L., Scholz, H., & Steinfath, M. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050172 · Cited by 89
Lefèbvre, H., Contesse, V., Delarue, C., Soubrane, C., Legrand, A., Kuhn, J., Wolf, L. M., & Vaudry, H. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263156 · Cited by 88
Zeeman, G. G., & Dekker, G. (1992) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-199206000-00014 · Cited by 87
Serotonin Transporter Gene Polymorphism and Myocardial Infarction
Fumeron, F., Betoulle, D., Nicaud, V., Evans, A., Kee, F., Ruidavets, J., Arveiler, D., Luc, G., & Cambien, F. (2002) · Circulation · doi:10.1161/01.cir.0000022603.92986.99 · Cited by 84
Ozaki, N., Rosenthal, N. E., Pesonen, U., Lappalainen, J., Feldman‐Naim, S., Schwartz, P. J., Turner, E. H., & Goldman, D. A. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00649-4 · Cited by 83
Lefèbvre, H., Compagnon, P., Contesse, V., Delarue, C., Thuillez, C., Vaudry, H., & Kuhn, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7917 · Cited by 83
His452Tyr Polymorphism in the Human 5-HT2A Receptor Destabilizes the Signaling Conformation
Hazelwood, L. A., & Sanders‐Bush, E. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.5.1293 · Cited by 80
Ohtsuki, T., Ishiguro, H., Detera‐Wadleigh, S. D., Toyota, T., Shimizu, H., Yamada, K., Yoshitsugu, K., Hattori, E., Yoshikawa, T., & Arinami, T. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001133 · Cited by 80
5‐HT 1B Receptor Polymorphism and Clinical Response to Sumatriptan
MaassenVanDenBrink, A., Vergouwe, M. N., Ophoff, R. A., Saxena, P. R., Ferrari, M. D., & Frants, R. R. (1998) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3804288.x · Cited by 80
Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon
Biondi, M. L., Marasini, B., Bianchi, E., & Agostoni, A. (1988) · International Journal of Cardiology · doi:10.1016/0167-5273(88)90238-0 · Cited by 78
Whyte, E. M., Pollock, B. G., Wagner, W. R., Mulsant, B. H., Ferrell, R. E., Mazumdar, S., & Reynolds, C. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2074 · Cited by 78
Brattelid, T., Qvigstad, E., Lynham, J. A., Molenaar, P., Aass, H., Geiran, O. R., Skomedal, T., Osnes, J. B., Levy, F. O., & Kaumann, A. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0963-0 · Cited by 77
Self-citationSerotonin 5-HT2 Receptors: Molecular and Genomic Diversity
Sanders‐Bush, E., Fentress, H., & Hazelwood, L. (2003) · Molecular Interventions · doi:10.1124/mi.3.6.319 · Cited by 77
Serebruany, V. L., Glassman, A. H., Malinin, A., Atar, D., Sane, D. C., Oshrine, B. R., Ferguson, J. J., & O’Connor, C. M. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00005-9 · Cited by 74
Yamada, S., Akita, H., Kanazawa, K., Ishida, T., Hirata, K., Ito, K., Kawashima, S., & Yokoyama, M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00356-1 · Cited by 72
A 5-HT4-like receptor in human left atrium
Sanders, L., & Kaumann, A. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00176614 · Cited by 72
Self-citationConstitutive dimerization of human serotonin 5‐HT4 receptors in living cells
Berthouze, M., Ayoub, M. A., Russo, O., Rivail, L., Sicsic, S., Fischmeister, R., Berque‐Bestel, I., Jockers, R., & Lezoualc’h, F. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.040 · Cited by 71
Mialet‐Perez, J., Berque‐Bestel, I., Eftekhari, P., Gastineau, M., Giner, M., Dahmoune, Y., Donzeau‐Gouge, P., Hoebeke, J., Langlois, M., Sicsic, S., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703101 · Cited by 71
Bateman, D. N. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614304 · Cited by 71
Preactivation Permits Subsequent Stimulation of Phospholipase C by Gi-Coupled Receptors
Chan, J. S. C., Lee, J. W. M., Ho, M. K. C., & Wong, Y. H. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.700 · Cited by 71
Coto, E., Reguero, J. R., Álvarez, V., Morales, B., Batalla, A., González, P., Martı́n, M., Garcı́a-Castro, M., Iglesias-Cubero, G., & Cortina, A. (2003) · Clinical Science · doi:10.1042/cs1040241 · Cited by 70
Ullmer, C., Boddeke, H. W. G. M., Schmuck, K., & Lübbert, H. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16700.x · Cited by 70
Mechanisms Mediating Bradycardia during Coronary Arteriography
Eckberg, D. L., White, C. W., Kioschos, M., & Abboud, F. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107893 · Cited by 67
Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle
Jahnel, U., Rupp, J., Ertl, R., & Nawrath, H. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169000 · Cited by 67
Rahme, M. M., Cotter, B. R., Leistad, E., Wadhwa, M. K., Mohabir, R., Ford, A. P. D. W., Eglen, R. M., & Feld, G. K. (1999) · Circulation · doi:10.1161/01.cir.100.19.2010 · Cited by 66
Kaiser, R., Tremblay, P., Sezer, O., Possinger, K., Roots, I., & ller, J. R. B. (2004) · Pharmacogenetics · doi:10.1097/00008571-200405000-00001 · Cited by 65
Identification of Genetic Variation in the Human Serotonin 1Dβ Receptor Gene
Nöthen, M. M., Erdmann, J., Shimron‐Abarbanell, D., & Propping, P. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2792 · Cited by 64
Cloning and Expression of a Human Serotonin 5‐HT4 Receptor cDNA
den Wyngaert, I. V., Gommeren, W., Verhasselt, P., Jurzak, M., Leysen, J. E., Luyten, W. H. M. L., & Bender, E. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051810.x · Cited by 62
A Synergistic Effect of Serotonin Transporter Gene Polymorphism and Smoking in Association with CHD
Ohtsuki, T., Yamakawa‐Kobayashi, K., Amemiya, H., Fujiwara, H., Kawata, K.-I., Ishiguro, H., Hamaguchi, H., & Arinami, T. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614586 · Cited by 61
Cigler, T., LaForge, K. S., McHugh, P. F., Kapadia, S. U., Leal, S. M., & Kreek, M. J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1473 · Cited by 60
Identification of mRNA for 5-HT1 and 5-HT2 receptor subtypes in human coronary arteries
Ishida, T., Hirata, K., Sakoda, T., Kawashima, S., Akita, H., & Yokoyama, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00162-x · Cited by 59
Mialet‐Perez, J., Berque‐Bestel, I., Sicsic, S., Langlois, M., Fischmeister, R., & Lezoualc’h, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703641 · Cited by 59
McCormick, P. A., Dick, R., Graffeo, M., et al. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90117-a · Cited by 58
Blanpain, C. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.015 · Cited by 57
Raymond, J. R., Kim, J., Beach, R. E., & Tisher, C. C. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.264.1.f9 · Cited by 57
Hadengue, A., Moreau, R., Cerini, R., Koshy, A., Lee, S. S., & Lebrec, D. (1989) · Hepatology · doi:10.1002/hep.1840090113 · Cited by 56
STIMULATION OF ALDOSTERONE BIOSYNTHESIS IN VITRO BY SEROTONIN
Müller, J., & Ziegler, W. H. (1968) · European Journal of Endocrinology · doi:10.1530/acta.0.0590023 · Cited by 55
Caccia, S., Conforti, I., Duchier, J. L., et al. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00547426 · Cited by 54
5‐HT4 Receptors: Cloning and Expression of New Splice Variants
Claeysen, S., Faye, P., Sebben, M., Taviaux, S. A., Bockaert, J., & Dumuis, A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10172.x · Cited by 54
Fu, L., & Longhurst, J. C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.023374 · Cited by 53
Schoeffter, P., Ullmer, C., Bobirnac, I., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16687.x · Cited by 53
DNA variation and psychopharmacology of the human serotonin receptor 1B(HTR1B) gene
Sanders, A. R., Duan, J., & Gejman, P. V. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.6.745 · Cited by 52
Association of a haplotype in the serotonin 5‐HT4 receptor gene (HTR4) with Japanese schizophrenia
Suzuki, T., Iwata, N., Kitamura, Y., Kitajima, T., Yamanouchi, Y., Ikeda, M., Nishiyama, T., Kamatani, N., & Ozaki, N. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20060 · Cited by 52
McFadden, E., Bauters, C., Lablanche, J. M., Leroy, F., Clarke, J. G., Henry, M., Schandrin, C., DAVIES, G. J., Maseri, A., & Bertrand, M. E. (1992) · Circulation · doi:10.1161/01.cir.86.1.187 · Cited by 51
How structurally normal are human atria in patients with atrial fibrillation?
Becker, A. E. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.09.009 · Cited by 50
Lefèbvre, H., Cartier, D., Duparc, C., Lihrmann, I., Contesse, V., Delarue, C., Godin, M., Fischmeister, R., Vaudry, H., & Kuhn, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8327 · Cited by 50
Contesse, V., Hamel, C. P., Lefèbvre, H., Dumuis, A., Vaudry, H., & Delarue, C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08735-8 · Cited by 50
Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin
Rothman, R. B., Redmon, J. B., Raatz, S. K., Kwong, C. A., Swanson, J. E., & Bantle, J. P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00896-6 · Cited by 47
Erdmann, J., Nöthen, M. M., Shimron‐Abarbanell, D., Rietschel, M., Albus, M., Borrmann, M., Maier, W., Franzek, E., Körner, J., Weigelt, B., et al. (1996) · PubMed · Cited by 47
Blood and Plasma 5–Hydroxytryptamine Levels in Patients With Cirrhosis
Beaudry, P., Hadengue, A., Callebert, J., et al. (1994) · Hepatology · doi:10.1002/hep.1840200405 · Cited by 46
Elhusseiny, A., & Hamel, É. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703763 · Cited by 45
Prins, N. H., Shankley, N. P., Welsh, N. J., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703254 · Cited by 45
Identification of Two Serine Residues Essential for Agonist-Induced 5-HT2AReceptor Desensitization
Gray, J. A., Compton-Toth, B. A., & Roth, B. L. (2003) · Biochemistry · doi:10.1021/bi035061z · Cited by 45
Expression and Regulation of Adenylyl Cyclase Isoforms in the Human Adrenal Gland
Côté, M., Guillon, G., PAYET, M. D., & Gallo‐Payet, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7837 · Cited by 43
Cited by
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
“Serotonin causes vasoconstriction or vasodilation in different vascular beds depending on the particular receptors that are expressed in each vessel wall and surrounding smooth muscle tissue (19).”
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule
Yabut, J. M., Crane, J. D., Green, A. E., Keating, D. J., Khan, W. I., & Steinberg, G. R. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00283 · Cited by 411
Mechanisms of Coronary Artery Spasm
Lanza, G. A., Careri, G., & Crea, F. (2011) · Circulation · doi:10.1161/circulationaha.111.037283 · Cited by 401
Metadata
- Authors
- Kaumann, A. J., & Levy, F. O.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 111
- Issue
- 3
- Pages
- 674-706
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2159601487
- Cited by
- 309
- References
- 240
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.